Skip to main content
Premium Trial:

Request an Annual Quote

Genomatix Expands NCI Software Licensing Agreement

NEW YORK, May 31 (GenomeWeb News) - Genomatix has expanded its existing licensing agreement with the National Cancer Institute, allowing NCI scientists more seats and full access to its BiblioSphere PathwayEdition pathway knowledge base and analysis software.


Specific terms of the deal were not disclosed.


BiblioSphere PathwayEdition allows dynamic data-driven pathway construction and analysis based on literature, the Genomatix Knowledge Base Ontology, and sequence analysis, Genomatix said.

The Scan

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.

Genome Biology Papers on GWAS Fine-Mapping Method, COVID-19 Susceptibility, Rheumatoid Arthritis

In Genome Biology this week: integrative fine-mapping approach, analysis of locus linked to COVID-19 susceptibility and severity, and more.